Literature DB >> 2985608

Binding of apolipoprotein A-I and A-II after recombination with phospholipid vesicles to the high density lipoprotein receptor of luteinized rat ovary.

J Hwang, K M Menon.   

Abstract

To determine the apolipoprotein specificity of high density lipoprotein (HDL) receptor, apolipoprotein A-I (apo-AI) and apolipoprotein A-II (apo-AII) purified from high density lipoprotein3 (HDL3) were reconstituted into dimyristoyl phosphatidylcholine vesicles (DMPC) and their ability to bind to luteinized rat ovarian membranes was examined. Both 125I-apo-A-I.DMPC and 125I-apo-A-II.DMPC were shown to bind to ovarian membranes with Kd = 2.87 and 5.70 micrograms of protein/ml, respectively. The binding of both 125I-apo-A-I.DMPC and 125I-apo-A-II.DMPC was inhibited by unlabeled HDL3, apo-A-I.DMPC, apo-A-II.DMPC, apo-C-I.DMPC, apo-C-II.DMPC, apo-C-III1.DMPC, and apo-C-III2.DMPC, but not by DMPC vesicles, bovine serum albumin.DMPC or low density lipoprotein. Since the binding labeled apo-A-I.DMPC and apo-A-II.DMPC was inhibited by the DMPC complexes of apo-C groups, the direct binding of 125I-apo-C-III1.DMPC was also demonstrated with Kd = 9.6 micrograms of protein/ml. In addition, unlabeled apo-A-I.DMPC, and apo-A-II.DMPC, as well as apo-C.DMPC, inhibited 125I-HDL3 binding. 125I-apo-A-I, 125I-apo-A-II, and 125I-apo-C-III1 in the absence of DMPC also bind to the membranes. These results suggest that HDL receptor recognizes apolipoprotein AI, AII, and the C group and that the binding specificity of the reconstituted lipoproteins is conferred by their apolipoprotein moiety rather than the lipid environment. In vivo pretreatment of rats with human chorionic gonadotropin resulted in an increase of 125I-apo-A-I.DMPC, 125I-apo-A-II.DMPC, and 125I-apo-C-III1.DMPC binding activities. However, no induction of binding activity was observed when the apolipoprotein was not included in DMPC vesicles. An examination of the equilibrium dissociation constant and binding capacity for 125I-apo-A-I.DMPC and 125I-apo-A-II.DMPC after human chorionic gonadotropin treatment revealed that the increase in binding activity was due to an increase in the number of binding sites rather than a change in the binding affinity. These results further support our contention that apo-A-I, apo-A-II, and the apo-C group bind to HDL receptor. In conclusion, the HDL receptor of luteinized rat ovary recognizes apolipoproteins A-I, A-II, and the C group but not low density lipoprotein, and the binding is induced by human chorionic gonadotropin in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985608

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Characterization and isolation of a high-density-lipoprotein-binding protein from bovine corpus luteum plasma membrane.

Authors:  K Ferreri; K M Menon
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  Induction of high-density-lipoprotein receptors in rat corpus luteum by human choriogonadotropin. Evidence of protein synthesis de novo.

Authors:  D K Ghosh; K M Menon
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

3.  A two-dimensional electrophoresis reference map of human ovary.

Authors:  Lei Wang; Ye-Fei Zhu; Xue-Jiang Guo; Ran Huo; Xiang Ma; Min Lin; Zuo-Min Zhou; Jia-Hao Sha
Journal:  J Mol Med (Berl)       Date:  2005-07-15       Impact factor: 4.599

4.  Characterization and purification of proteins which bind high-density lipoprotein. A putative cell-surface receptor.

Authors:  H M Bond; G Morrone; S Venuta; K E Howell
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

5.  The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.

Authors:  P K Vadiveloo; N H Fidge
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

6.  HDL3-mediated cholesterol efflux from cultured enterocytes: the role of apoproteins A-I and A-II.

Authors:  G Herold; U Hesse; F Wisst; C Fahr; M Fahr; G Rogler; I Geerling; E F Stange
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

7.  Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

Authors:  A von Eckardstein; H Holz; M Sandkamp; W Weng; H Funke; G Assmann
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

8.  Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.

Authors:  C M Allan; N H Fidge; J R Morrison; J Kanellos
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

9.  Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters.

Authors:  M N Pieters; G R Castro; D Schouten; P Duchateau; J C Fruchart; T J Van Berkel
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

10.  A recombinant apoA-1--protein A hybrid reproduces the binding parameters of HDL to its receptor.

Authors:  L Monaco; H M Bond; K E Howell; R Cortese
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.